Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

An Army nurse holds a vial of the Johnson & Johnson vaccine at the FEMA-supported COVID-19 vaccination site at Valencia State College on April 25. Photo: Paul Hennessy/SOPA Images/LightRocket via Getty Images

About 3 in 4 unvaccinated adult Americans are unwilling to get the Johnson & Johnson coronavirus vaccine, a Washington Post-ABC News poll out Monday indicates.

Why it matters: Less than half of all U.S. adults polled said they thought the J&J shot — which presents fewer logistical challenges than the more temperature-controlled, two-shot Pfizer and Moderna vaccines — is safe.

What they found: Roughly half of the unvaccinated adults who were polled said that the Moderna and Pfizer vaccines are safe. Fewer than 1 in 3 said the same for Johnson & Johnson.

  • A majority of the 44% who said in the poll that they were unvaccinated indicated that they definitely or probably not get inoculated.
  • Republican-leaning adults aged 18 to 39 were the most reluctant to get vaccinated in the Post-ABC News poll — 55% said they definitely or probably would not get immunized.

Methodology: Post-ABC News poll conducted by telephone among a random national sample of 1,007 adults from April 18-21. 75% were reached on cellphones and 25% on landlines. Margin of error ± 3.5 percentage points for full sample.

Go deeper

Biden's 100-day numbers: Vaccinated Americans

Data: CDC via Our World in Data; Chart: Will Chase/Axios

Joe Biden promised as president-elect to get 100 million coronavirus vaccine shots in American arms during his first 100 days in office; since taking office, he's more than doubled that goal — and more than a quarter of Americans are now fully vaccinated.

By the numbers: Not quite 1% were vaccinated when Biden took office, although the Trump administration managed to reach an important milestone of 1 million doses administered in a day.

Apr 26, 2021 - Health

The next wave of the pandemic: Long Covid

Illustration: Annelise Capossela/Axios

The research is becoming only more clear: People who have had COVID — even those who never had severe infections — are at risk of ongoing health problems, including some serious ones.

Why it matters: Long after the majority of Americans are vaccinated, patients and the U.S. health system will likely bear the brunt of millions of people who are struggling to get back to normal.

The E.U. will allow vaccinated Americans to visit this summer

Dome of Positano on the Amalfi Coast in Italy. Photo: Daniele Orsi/REDA&CO/Universal Images Group via Getty Images

The E.U. is planning to allow fully vaccinated Americans to visit and travel within its borders this summer, European Commission President Ursula von der Leyen told the New York Times Sunday.

Why it matters: Von der Leyen didn't specify when the rules will officially be relaxed, but the prospect of opening up tourism to Americans displays a buoyed confidence in the both the American and E.U. vaccination campaigns.